As policy uncertainty, public scrutiny, and evolving regulations reshape the pharmaceutical landscape, business decisions have never carried greater strategic risk. Hear industry leaders discuss how they're navigating the intersection of policy, reputation, and corporate strategy to build resilience in an increasingly complex healthcare environment.
